arGEN-X's Grant - II Round

arGEN-X raised a round of funding on September 27, 2010. Investors include VLAIO.

arGEN-X (EBR: ARGX) (NASDAQ: ARGX) is a clinical stage human therapeutic antibody company that is rapidly developing a product pipeline using its unique suite of antibody technologies. arGEN-X is crea…

Articles about arGEN-X's Grant - II Round: